Why Is LUMEXA IMAGING HLDGS (LMRI) Stock Up Today?

Lumexa Imaging Holdings (LMRI) shares rose 14.58% to $15.95, driven by a strong third quarter earnings report and a significant upgrade in fiscal 2026 guidance. The company posted results that exceeded analyst expectations, prompting immediate positive reactions from Wall Street analysts.

What Happened

Lumexa reported third quarter non-GAAP EPS of $0.26, beating the consensus estimate of $0.18 by $0.08. Revenue came in at $272 million, up 5.1% year over year and exceeding estimates by $2.11 million. The company narrowed its adjusted EBITDA guidance for fiscal 2026 to a range of $236 million to $240 million. Management raised its adjusted EPS guidance for the full year from a previous range of $0.71 to $0.77 to a new range of $0.86 to $0.90, well above the prior estimate of $0.77. The company also reaffirmed its fiscal 2026 sales guidance of $1.045 billion to $1.097 billion. Raymond James raised its price target for the stock from $17 to $19 following the earnings beat. The company outlined a target of at least 30% free cash flow conversion for 2026 while identifying a total addressable market of roughly $77 billion.

What The Data Shows

The stock has gained 22.0% over the last eight sessions, moving from $11.41 to $13.92 before the latest jump. Lumexa printed six fresh 52-week highs and one fresh 52-week low on November 11, 2026. The company currently has a market capitalization of $1.3 billion. It remains unprofitable on a trailing twelve-month basis with an EPS of negative $0.33 and a net margin of negative 2.7%. Revenue growth stands at 7.8% on a trailing twelve-month basis. The 52-week range for the stock is $6.45 to $19.45.

What To Watch

Investors will monitor the company's progress toward its raised adjusted EPS guidance and its ability to achieve the targeted free cash flow conversion rate in the coming quarters.